FDA Approves Pediatric Cancer Drug

March 11, 2015 8:34 PM

4 0

The U.S. Food and Drug Administration (FDA) has approved Unituxin (dinutuximab), part of a first-line therapy for high-risk neuroblastoma.

The new treatment is approved for use in combination with surgery, chemotherapy and radiation therapy for patients who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

Read more

To category page

Loading...